Pdude, As Amarin investors we need to continuously circle back to see what condition our condition is in. If that study was funded and conducted properly it would have reached statistical significance. (My opinion) The CVD indication that we have should generate billions in sales. I don't think Amarin should spend the money to conduct clinical trials at the moment. Once Europe becomes a cash generating machine things might be different. I am still convinced that our investment here will pay off. Probably better than most of us currently think. Try not to take your work home. If I was in your position I would be tempted. Sleven,
Well they are finding Omricon in Sacramento waste water … key recruiting area for MITIGATE. The Vascepa / Covid trials aren’t over yet Data late Feb / March 2022
Market Data 
Markets 
AI
